Categories AlphaGraphs, Earnings, U.S. Markets News

Quarterly profit climbs 21% for Kinder Morgan

Kinder Morgan (KMI), which controls North America’s largest network of natural gas pipelines, reported a 20.9% jump in first-quarter earnings on almost flat revenue. Net earnings rose to $485 million from $401 million, while earnings per share jumped 22.2% to $0.22. The earnings bump was helped by the performance of the company’s natural gas and Co2 business units. Kinder Morgan beat analysts’ EPS estimates for the quarter, while missed on revenue estimates.

The company raised its dividend by 60% to $0.20 per share from the earlier dividend of $0.1250. For the first quarter, Kinder Morgan reported distributable cash flow (DCF) of $0.56 per share, up 4% year-over-year, resulting in $804 million in excess DCF above the company’s dividend.

KMI completed about $700 million of projects in the quarter while adding about $900 million of new projects to its backlog during the first quarter.

“Even with the substantial dividend increase, we still expect to internally fund all of our growth capital with some excess remaining. During the first quarter, we made substantial progress on the Elba Liquefaction Project and began work on the Gulf Coast Express Project. We had very good commercial and operating performance,” said CEO Steve Kean.

KMI stock jumped almost 3% after trading hours post earnings release.

Outlook

For 2018, the company expects to report DCF of about $4.57 billion and adjusted EBITDA of about $7.5 billion.

Kinder Morgan sees DCF and Adjusted EBITDA meeting or exceeding its targets for the year. The company also expects to invest $2.3 billion in growth projects, up $100 million from what was budgeted and is to be funded with internally generated cash flows alone.

Kinder Morgan earnings results

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top